1. Tissue Engineering in Osteoarthritis: Current Status and Prospect of Mesenchymal Stem Cell Therapy

   • Gun-Il Im

   Leading Article 27 April 2018 Pages: 183 - 192

2. Efficacy and Safety Outcomes for Originator TNF Inhibitors and Biosimilars in Rheumatoid Arthritis and Psoriasis Trials: A Systematic Literature Review

   • Robert J. Moots
   • Cinzia Curiale
   • Eduardo Mysler

   Systematic Review 22 May 2018 Pages: 193 - 199

   

3. Therapeutic Targeting of the Interleukin-4/Interleukin-13 Signaling Pathway: In Allergy and Beyond

   • Danielle Karo-Atar
   • Almog Bitton
   • Ariel Munitz

   Review Article 07 May 2018 Pages: 201 - 220

   

4. Overcoming Tumor-Induced Immune Suppression: From Relieving Inhibition to Providing Costimulation with T Cell Agonists

   • Dana A. Emerson
   • William L. Redmond

   Review Article 10 April 2018 Pages: 221 - 231

   

5. Anticalin^® Proteins as Therapeutic Agents in Human Diseases

   • Christine Rothe
   • Arne Skerra

   Review Article Open access 10 May 2018 Pages: 233 - 243

   

6. Humanized Mouse Models for the Preclinical Assessment of Cancer Immunotherapy

   • Anja Kathrin Wege

   Review Article 27 March 2018 Pages: 245 - 266

   

7. Knowledge of Adverse Drug Reaction Reporting and the Pharmacovigilance of Biological Medicines: A Survey of Healthcare Professionals in Ireland

   • J. O’Callaghan
   • B. T. Griffin
   • Margaret Bermingham

   Original Research Article Open access 02 May 2018 Pages: 267 - 280

   

8. Determining the Value of Two Biologic Drugs for Chronic Inflammatory Skin Diseases: Results of a Multi-Criteria Decision Analysis

   • Néboa Zozaya
   • Lucía Martínez-Galdeano
   • Álvaro Hidalgo-Vega

   Original Research Article Open access 29 May 2018 Pages: 281 - 291

   

9. SB3 (Ontruzant^®): A Trastuzumab Biosimilar

   • Yvette N. Lamb

   Adis Biosimilar Brief 23 May 2018 Pages: 293 - 296